The technology is an immunoassay based on monoclonal antibodies, which is intended for early detection of the capsular antigen associated with B. anthracis—the anthrax bacterium.
Using a retroviral technique to immortalize antibody secreting cells, NeoClone is able to produce monoclonal antibodies that can be used in multiplexed analyte detection formats. By using a viral i...